Immunodominance and recognition of intracellular pathogens

Journal of Infectious Diseases

Volumn 198, Issue 11, 2008, Pages 1579-1581

  Wilson, Emma H ^a   Hunter, Christopher A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PARASITE ANTIGEN;

CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; DENDRITIC CELL; DISEASE DURATION; EDITORIAL; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; LIFE CYCLE; LISTERIA; LYMPHOCYTE SUBPOPULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PARASITE; PRIORITY JOURNAL; TOXOPLASMOSIS;

ANTIGENS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COMMUNICABLE DISEASES; HUMANS; IMMUNODOMINANT EPITOPES;

EID: 56649106582     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/593020     Document Type: Editorial

References (14)

1. Khan IA, Ely KH, Kasper LH. Antigen-specific CD8+ T cell clone protects against acute Toxoplasma gondii infection in mice. J Immunol 1994; 152:1856-60.
2. Pepper M, Dzierszinski F, Crawford A, Hunter CA, Roos D. Development of a system to study CD4+-T-cellresponsestotransgenicovalbumin-expressing Toxoplasma gondii during toxoplasmosis. Infect Immun 2004; 72:7240-6.
3. Gubbels MJ, Striepen B, Shastri N, Turkoz M, Robey EA. Class I major histocompatibility complex presentation of antigens that escape from the parasitophorous vacuole of Toxoplasma gondii. Infect Immun 2005; 73:703-11.
4. Dzierszinski F, Pepper M, Stumhofer JS, et al. Presentation of Toxoplasma gondii antigens via the endogenous major histocompatibility complex class I pathway in nonprofessional and professional antigen-presenting cells. Infect Immun 2007; 75:5200-9.
5. Dzierszinski FS, Hunter CA. Advances in the use of genetically engineered parasites to study immunity to Toxoplasma gondii. Parasite Immunol 2008; 30:235-44.
6. Kwok LY, Lutjen S, Soltek S, et al. The induction and kinetics of antigen-specific CD8 T cells are defined by the stage specificity and compartmentalization of the antigen in murine toxoplasmosis. J Immunol 2003; 170:1949-57.
7. + T cell epitopes J Infect Dis 2008; 198:1625-33 (in this issue).
8. Toebes M, Coccoris M, Bins A, et al. Design and use of conditional MHC class I ligands. Nat Med 2006; 12:246-51.
9. Bakker AH, Hoppes R, Linnemann C, et al. Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7. Proc Natl Acad Sci U S A 2008; 105:3825-30.
10. Grotenbreg GM, Roan NR, Guillen E, et al. Discovery of CD8+ T cell epitopes in Chlamydia trachomatis infection through use of caged class I MHC tetramers. Proc Natl Acad Sci U S A 2008; 105:3831-6.
11. Blanchard N, Gonzalez F, Schaeffer M, et al. Immunodominant, protective response to the parasite Toxoplasma gondii requires antigen processing in the endoplasmic reticulum. Nat Immunol 2008; 9:937-44.
12. Labruyere E, Lingnau M, Mercier C, Sibley LD. Differential membrane targeting of the secretory proteins GRA4 and GRA6 within the parasitophorous vacuole formed by Toxoplasma gondii. Mol Biochem Parasitol 1999; 102:311-24.
13. Laliberte J, Carruthers VB. Host cell manipulation by the human pathogen Toxoplasma gondii. Cell Mol Life Sci 2008; 65:1900-15.
14. Desolme B, Mevelec MN, Buzoni-Gatel D, Bout D. Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene. Vaccine 2000; 18:2512-21.